Skip to content

Clinical trials

Phase 1 Peanut Hypersensitivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peanut Hypersensitivity Phase: Phase 1 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20102
20142
20162
20172
20192
20212
20222
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2
Active, not recruiting1
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.2
COUR Pharmaceutical Development Company, Inc.2
DBV Technologies2
Allergy Therapeutics1
Allertein Therapeutics, LLC1
Alton Melton1
Baylor College of Medicine1
Beth Israel Deaconess Medical Center1
HAL Allergy1
Insignis Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peanut Hypersensitivity19
Food Hypersensitivity8
Hypersensitivity4
Anaphylaxis2
Hypersensitivity, Immediate2
Nut Hypersensitivity1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.